IBERE PHARMACEUTICALS reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Philadelphia, PA
SEC filing record 1 source field available
Fiscal year end
31 December
IBERE PHARMACEUTICALS has filed 51 SEC EDGAR filings since 07 Dec 2020

SEC filing history

Showing 1-25 of 51 matching filings.

Per page
25
Current page
1
15-12G File 001-40119

15-12G

Filing date
13 Mar 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
25-NSE File 001-40119

25-NSE filing

Filing date
02 Mar 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-92346

SC 13G filing

Filing date
14 Feb 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-92346

SC 13G/A

Filing date
14 Feb 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-92346

IBER 13G

Filing date
08 Feb 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-92346

SCHEDULE 13G (AMENDMENT NO. 1)

Filing date
08 Feb 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-92346

SC 13G/A

Filing date
02 Feb 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-92346

IBERE PHARMACEUTICALS

Filing date
14 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-92346

SC 13G

Filing date
08 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-92346

SCHEDULE 13G

Filing date
14 Jan 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-92346

SCHEDULE 13G

Filing date
27 Sep 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K/A File 001-40119

FORM 8-K/A

Filing date
16 Aug 2021
Reporting date
02 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-40119

FORM 8-K

Filing date
13 Aug 2021
Reporting date
10 Aug 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-40119

FORM 8-K

Filing date
04 Aug 2021
Reporting date
29 Jul 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-40119

FORM 8-K

Filing date
28 May 2021
Reporting date
25 May 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
NT 10-Q File 001-40119

NT 10-Q

Filing date
18 May 2021
Reporting date
31 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .